Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
MORE►
Pfizer Inc.
Daniel Siegwart, Ph.D., is Director of the Program in Genetic Drug Engineering, Professor of Biomedical Engineering and Biochemistry, and a member of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern. [Photo: UT Southwestern]
UT Southwestern Collaborates With Pfizer to Develop Better RNA Delivery Tech
by Lance Murray | Feb 13, 2024
UT Southwestern Medical Center and pharmaceutical company Pfizer have teamed up to develop new ways to deliver genetic treatments to patients.
Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
by Alex Edwards |
Sep 10, 2020
COVID-19 delayed the opening of a 3D-printed display from Lyda Hill Philanthropies IF/THEN Initiative of the most statues of women ever assembled. Starting Sept. 10, the exhibit is instead doing a pop-up near Macy’s Court.
MORE►
